よむ、つかう、まなぶ。
【参考資料２－２】抗微生物薬適正使用の手引き 第四版（案）医科・入院編 (45 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64503.html |
| 出典情報 | 厚生科学審議会 感染症部会（第99回 10／21）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
抗微生物薬適正使用の手引き
第四版
医科・入院編
1
2
87. Japanese Respiratory Society. Strategies for non-responders. Respirology. 2009. 14
Suppl 2:S41-3.
3
4
5
88. Macfarlane JT, et al. Comparative radiographic features of community acquired
Legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia, and
psittacosis. Thorax. 1984. 39(1):28-33.
6
89. Pappas PG, et al. Invasive candidiasis. Nat Rev Dis Primers. 2018. 4:18026.
7
8
90. Ioanas M, et al. Causes and predictors of nonresponse to treatment of intensive care
unit-acquired pneumonia. Crit Care Med. 2004. 32(4):938-945.
9
91. Raff AB, et al. Cellulitis: A Review. JAMA. 2016. 316(3):325-337.
10
11
92. Nathwani D, et al, Implementing criteria-based early switch/early discharge
programmes: a European perspective. Clin Microbiol Infect. 2015. 21 Suppl 2: S47-55.
12
13
93. ANTIMICROBIAL STEWARDSHIP FROM PRINCIPLES TO PRACTICE 2018 British
Society for Antimicrobial Chemotherapy
14
15
94. 野本英俊, 他. 経口抗菌薬へのスイッチを再考する. KANSEN Journal No.73
（2019.7.29）
16
17
18
95. Sevinç F, et al. Early switch from intravenous to oral antibiotics: guidelines and
implementation in a large teaching hospital. J Antimicrob Chemother. 1999. 43(4):601606.
19
20
96. Cyriac JM, et al. Switch over from intravenous to oral therapy: A concise overview. J
Pharmacol Pharmacother. 2014. 5(2): 83-87.
21
97. 抗菌薬適正使用生涯教育テキスト 第 3 版
22
98. 日本化学療法学会 抗菌薬 TDM 臨床実践ガイドライン 2022
23
24
99. Nilsson-Ehle I. et al. Pharmacokinetics of clavulanic acid, given in combination with
amoxycillin, in volunteers. J Antimicrob Chemother. 1985. 16(4):491-498.
25
26
100. Baghban A, et al. Antimicrobial Use at the End of Life. Infec Dis Clin North Am. 2017.
Dec(4):639-647.
27
28
29
101. Barlam TF. et al. Implementing an Antibiotic Stewardship Program: Guidelines by the
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of
America. Clin Infect Dis. 2016. 62(10): e51-77
30
45
第四版
医科・入院編
1
2
87. Japanese Respiratory Society. Strategies for non-responders. Respirology. 2009. 14
Suppl 2:S41-3.
3
4
5
88. Macfarlane JT, et al. Comparative radiographic features of community acquired
Legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia, and
psittacosis. Thorax. 1984. 39(1):28-33.
6
89. Pappas PG, et al. Invasive candidiasis. Nat Rev Dis Primers. 2018. 4:18026.
7
8
90. Ioanas M, et al. Causes and predictors of nonresponse to treatment of intensive care
unit-acquired pneumonia. Crit Care Med. 2004. 32(4):938-945.
9
91. Raff AB, et al. Cellulitis: A Review. JAMA. 2016. 316(3):325-337.
10
11
92. Nathwani D, et al, Implementing criteria-based early switch/early discharge
programmes: a European perspective. Clin Microbiol Infect. 2015. 21 Suppl 2: S47-55.
12
13
93. ANTIMICROBIAL STEWARDSHIP FROM PRINCIPLES TO PRACTICE 2018 British
Society for Antimicrobial Chemotherapy
14
15
94. 野本英俊, 他. 経口抗菌薬へのスイッチを再考する. KANSEN Journal No.73
（2019.7.29）
16
17
18
95. Sevinç F, et al. Early switch from intravenous to oral antibiotics: guidelines and
implementation in a large teaching hospital. J Antimicrob Chemother. 1999. 43(4):601606.
19
20
96. Cyriac JM, et al. Switch over from intravenous to oral therapy: A concise overview. J
Pharmacol Pharmacother. 2014. 5(2): 83-87.
21
97. 抗菌薬適正使用生涯教育テキスト 第 3 版
22
98. 日本化学療法学会 抗菌薬 TDM 臨床実践ガイドライン 2022
23
24
99. Nilsson-Ehle I. et al. Pharmacokinetics of clavulanic acid, given in combination with
amoxycillin, in volunteers. J Antimicrob Chemother. 1985. 16(4):491-498.
25
26
100. Baghban A, et al. Antimicrobial Use at the End of Life. Infec Dis Clin North Am. 2017.
Dec(4):639-647.
27
28
29
101. Barlam TF. et al. Implementing an Antibiotic Stewardship Program: Guidelines by the
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of
America. Clin Infect Dis. 2016. 62(10): e51-77
30
45